Among 285 female probands, most were breast cancer patients (98%), and 247 (86.7%), 15 (5.3%), and 23 (8.1%) were noncarriers, BRCA1, and BRCA2 carriers respectively. Here, BRCA1 is linked to breast carcinoma.